---
title: "Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer | GMAB Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282553850.md"
description: "Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer | GMAB Stock News"
datetime: "2026-04-13T05:35:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282553850.md)
  - [en](https://longbridge.com/en/news/282553850.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282553850.md)
---

# Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer | GMAB Stock News

Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer | GMAB Stock News

### Related Stocks

- [GMAB.US](https://longbridge.com/en/quote/GMAB.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)

## Related News & Research

- [Ernexa Therapeutics Stock Climbs On Breakthrough Preclinical Data](https://longbridge.com/en/news/285400985.md)
- [BioRestorative reports Phase 2 BRTX-100 data showing 52% hit pain, function endpoint](https://longbridge.com/en/news/285584056.md)
- [Verrica To Present Positive Phase 2 Data For VP-315 In Treating Basal Cell Carcinoma At SID Meeting](https://longbridge.com/en/news/285349672.md)
- [16:01 ETInnocan Pharma LPT-CBD is featured in Pain Medicine News](https://longbridge.com/en/news/285427579.md)
- [NBIX: Strong Crenessity and Ingrezza Outperformance, Robust 2026 Outlook and Pipeline Catalysts Underpin Buy Rating](https://longbridge.com/en/news/285267932.md)